EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matthews, C. P.
Right arrow Articles by McDougall, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matthews, C. P.
Right arrow Articles by McDougall, J. K.
Proceedings of the Society for Experimental Biology and Medicine 223:316-321 (2000)
© 2000 Society for Experimental Biology and Medicine

Original Article

Genomic Changes and HPV Type in Cervical Carcinoma

Connie P. Matthews*,{dagger}, Katherine A. Shera* and James K. McDougall*,{dagger},1


* Fred Hutchinson Cancer Research Center, Cancer Biology Program, Seattle, Washington 98109–1024; and
{dagger} Department of Pathology, University of Washington, Seattle, Washington 98195–7407

To identify chromosomal regions that may include the loci of abnormally expressed cellular genes and may be specifically altered depending on the histological subtype of the tumor, we studied primary cervical carcinoma using CGH and HPV genotyping. Eighty-seven percent of the primary tumors were positive for DNA of a "high-risk" HPV type (e.g., 16 or 18). In the cervical carcinomas, without reference to histologic subtype, overrepresentation of chromosome 3q was the most consistent chromosomal aberration with underrepresentation of chromosome 3p also a frequent finding. Chromosome arms 1q, 5p, 20q, and Xq were overrepresented in many tumors and 3p loss and 5p, 8q, and 16q gain were only associated with squamous cell carcinoma in this series.




This article has been cited by other articles:


Home page
 J. Mol. Diagn.Home page
I. Sokolova, A. Algeciras-Schimnich, M. Song, S. Sitailo, F. Policht, B. R. Kipp, J. S. Voss, K. C. Halling, A. Ruth, W. King, et al.
Chromosomal Biomarkers for Detection of Human Papillomavirus Associated Genomic Instability in Epithelial Cells of Cervical Cytology Specimens
J. Mol. Diagn., November 1, 2007; 9(5): 604 - 611.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Heselmeyer-Haddad, K. Sommerfeld, N. M. White, N. Chaudhri, L. E. Morrison, N. Palanisamy, Z. Y. Wang, G. Auer, W. Steinberg, and T. Ried
Genomic Amplification of the Human Telomerase Gene (TERC) in Pap Smears Predicts the Development of Cervical Cancer
Am. J. Pathol., April 1, 2005; 166(4): 1229 - 1238.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Heselmeyer-Haddad, V. Janz, P. E. Castle, N. Chaudhri, N. White, K. Wilber, L. E. Morrison, G. Auer, F. H. Burroughs, M. E. Sherman, et al.
Detection of Genomic Amplification of the Human Telomerase Gene (TERC) in Cytologic Specimens as a Genetic Test for the Diagnosis of Cervical Dysplasia
Am. J. Pathol., October 1, 2003; 163(4): 1405 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
N P H Chan, M H L Ng, S H Cheng, V Lee, K S Tsang, T T Lau, and C K Li
Hereditary duplication of proximal chromosome 1q (q11q22) in a patient with T lymphoblastic lymphoma/leukaemia: a family study using G banding and comparative genomic hybridisation
J. Med. Genet., December 1, 2002; 39(12): e79 - 79.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Experimental Biology and Medicine.